Search Results - "Zappacosta, Pamela S."
-
1
Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age
Published in Vaccine (01-02-2011)“…Abstract The current recommended infant vaccination schedules require many injections at multiple sites, which increase stress for infants and parents and may…”
Get full text
Journal Article -
2
Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age
Published in Vaccine (28-04-2009)“…Abstract Combination vaccines improve parental and provider satisfaction and schedule compliance by decreasing the number of injections. In a Phase 2,…”
Get full text
Journal Article -
3
Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children
Published in Human vaccines (04-11-2005)“…Combination vaccines decrease the number of injections and improve parental satisfaction and vaccination schedule compliance. In a phase 1, randomized,…”
Get full text
Journal Article -
4
Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children
Published in Human vaccines (01-11-2005)“…Combination vaccines decrease the number of injections and improve parental satisfaction and vaccination schedule compliance. In a phase 1, randomized,…”
Get full text
Journal Article -
5
Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaeb conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age
Published in Vaccine (28-04-2009)“…Combination vaccines improve parental and provider satisfaction and schedule compliance by decreasing the number of injections. In a Phase 2, randomized,…”
Get full text
Journal Article